The dynamics of integration, viral suppression and cell-cell transmission in the development of occult Hepatitis B virus infection
Introduction
Occult Hepatitis B virus (HBV) infection is defined as the long-lasting persistence of viral genetic material in the liver tissue of individuals with negativity for Hepatitis B surface antigen (HBsAg) with or without detectable HBV DNA in the serum (Pollicino and Raimondo, 2014, Raimondo et al., 2007). In the last decade, the understanding of occult hepatitis B virus infection has improved significantly largely due to concentrated efforts and technological advancements (Gutierrez-Garcia et al., 2011, Honarkar et al., 2004, Kwak and Kim, 2014, Martinez et al., 2015, Nishikawa and Osaki, 2013, Pollicino and Raimondo, 2014, Raimondo et al., 2007, Raimondo et al., 2013, Raimondo et al., 2008, Samal et al., 2012, Shire and Roberts, 2011, Squadrito et al., 2014, Zobeiri, 2013). Resultantly, occult hepatitis B virus infection in humans is further characterized into two categories as (i) occult hepatitis B virus infection seronegative (negative for anti-HBc and anti-HBs, termed as OBIAb-ve), and (ii) occult hepatitis B virus infection seropositive (positive for anti-HBc and anti-HBs, termed as OBIAb + ve). Additionally, “anti-HBc alone” where an individual is positive for anti-HBc, but negative for both HBsAg and anti-HBs is suspected (but not confirmed as it could also imply acute or resolved infection) as an atypical possible scenario of occult hepatitis B virus infection (Shire and Roberts, 2011, Wu et al., 2017a). In the ever-evolving natural history of HBV, occult hepatitis B virus infection is gaining recognition as one of the possible phases of chronic HBV infection (CHB) (Chemin and Trepo, 2005, McMahon, 2010, Pollicino and Raimondo, 2014). Although we have a good understanding of HBV life cycle and several phases in its natural progression (Ganem and Prince, 2004, McMahon, 2009), we still do not fully comprehended occult hepatitis B virus infection due to the lack of detectable serum biomarkers in this phase, in addition to the fact that there is an absolute need of invasive liver biopsy to confirm occult hepatitis B virus infection cases. For example, the reasons for the absence of HBsAg in the serum despite the presence of HBV genome/genetic material in the liver at low levels are not fully understood yet (Morales-Romero et al., 2014). occult hepatitis B virus infection is not only a challenge in clinical settings but also a serious issue in epidemiological settings as it stays below the radar and thus, the true HBV prevalence stays underestimated (Morales-Romero et al., 2014). This issue is further attenuated by the fact that infections with such low levels of HBV DNA during occult hepatitis B virus infection can still act as a source of infection transmission through blood transfusion and transplantation (Pollicino and Raimondo, 2014). Despite no signs of liver disease/damage in most of occult hepatitis B virus infection cases (Morales-Romero et al., 2014), occult hepatitis B virus infection still silently culminates in hepatocellular carcinoma, with or without cirrhosis but not in such high proportions as that of CHB (Pollicino and Raimondo, 2014).
Most importantly, mechanisms that can lead to occult hepatitis B virus infection are just speculative and require intense research (Morales-Romero et al., 2014). The list of such mechanisms include: (i) viral DNA integration, (ii) “a” determinant mutations leading to inefficient production of small-Hepatitis B surface antigen (S-HBsAg), (iii) the time elapsed since acute infection, (iv) a significant suppression of HBV replication (viral suppression), (v) immune factors such as non-cytolytic innate immune responses, (vi) genetic and epigenetic factors such as DNA methylation, which in large resembles like a significant viral suppression, (vii) coinfection with other viruses such as Hepatitis C virus (HCV) and human immunodeficiency virus (HIV), which also resembles like viral suppression, (viii) mutations in transcription-controlling regions of the polymerase, which resembles like points (ii) and (iv) together, and lastly, (ix) long half-life of hepatocytes and covalently closed-circular DNA (cccDNA) (Allweiss and Dandri, 2017, Hollinger and Sood, 2010, Huang et al., 2017, Kaur et al., 2010, Lucifora and Protzer, 2016, Morales-Romero et al., 2014, Pollicino and Raimondo, 2014, Pollicino et al., 2009).
In this article, we investigated the contribution of any combination of above-mentioned mechanism(s) in the transformation of acute HBV infection into occult hepatitis B virus infection. Investigations were conducted by employing mathematical forms of the HBV life cycle and experimental data sets, under one assumption that assays are ultra-sensitive and robust enough to detect occult hepatitis B virus infection without any misdiagnosis including no cases of false-positivity and false-negativity. Just like other viruses (Ciupe et al., 2007, Goyal and Murray, 2016, Goyal et al., 2017, Graw and Perelson, 2016, Ribeiro et al., 2010, Whalley et al., 2001), mathematical modeling can also play a vital role in the investigation of occult hepatitis B virus infection because (i) designing and conducting in vivo occult hepatitis B virus infection experiments is a time and resource consuming process as occult hepatitis B virus infection is a later phase of HBV infection which can take years to establish and even then it may not actually occur, and (ii) results from in vitro and in vivo experiments often varies from the human data (Allweiss and Dandri, 2017), and (iii) ultrasensitive molecular assays are unavailable, which could detect HBV at each and every step of the replication cycle. To the best of our knowledge, this is the first study that investigates occult hepatitis B virus infection from a modelling viewpoint.
Section snippets
Materials and methods
In this manuscript, we use the terminology: (i) infected hepatocytes: hepatocytes that have cccDNA, (ii) non-infected hepatocytes: hepatocytes with no cccDNA, and (iii) no productive integrated viral DNA: this implies that either there is no integrated DNA or if there is integrated DNA then there is no HBsAg production from them.
Significant viral suppression and no productive integrated viral DNA in non-infected hepatocytes is necessary to explain occult hepatitis B virus infection when the recirculation of nucleocapsids is the reason for cccDNA accumulation (Model 1)
From experimental observations, we have and, and using them in condition (2) yields , which is essential for PAHB transformation into occult hepatitis B virus infection. Therefore, mechanism(s) that can lead PAHB to occult hepatitis B virus infection are summarized as following (Fig. 2),
- (i)
By “a” determinant mutations: There is a need for a significant inhibition of the production of HBsAg from integrated viral DNA in infected hepatocytes and cccDNA
Discussion
The two hallmarks of occult Hepatitis B virus infection are serological negativity and the presence of miniscule HBV DNA loads (< 200 IU/ml) in the liver (Morales-Romero et al., 2014, Pollicino and Raimondo, 2014). It has been reported that out of all occult hepatitis B virus infection cases, there are about 78% positive for anti-HBc and anti-HBs (or, seropositive cases or OBIAb + ve) while the rest being negative for anti-HBc and anti-HBs (or, seronegative cases or OBIAb-ve) (Ocana et al., 2011
Acknowledgements
This work was supported by National Institutes of Health (Grant numbers R01-AI116868, R01-AI028433 and R01-OD011095). Portions of this work were performed under the auspices of the U.S. Department of Energy under contract DE-AC52-06NA25396. The funding sponsors had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, and in the decision to publish the results.
References (97)
- et al.
IL-10, T cell exhaustion and viral persistence
Trends Microbiol.
(2007) - et al.
Clinical impact of occult HBV infections
J. Clin. Virol.
(2005) - et al.
Modeling the mechanisms of acute Hepatitis B virus infection
J. Theor. Biol.
(2007) - et al.
Compartmental HBV evolution and replication in liver and extrahepatic sites after nucleos/tide analogue therapy in chronic Hepatitis B carriers
J. Clin. Virol.
(2017) - et al.
Metabolism and function of Hepatitis B virus cccDNA: implications for the development of cccDNA-targeting antiviral therapeutics
Antiviral. Res.
(2015) - et al.
Occult Hepatitis B virus infection with positive Hepatitis B e antigen
Clin. Chim Acta
(2015) - et al.
Reactivation from occult HBV carrier status is characterized by low genetic heterogeneity with the wild-type or G1896A variant prevalence
J. Hepatol.
(2014) - et al.
Diversity in T cell memory: an embarrassment of riches
Immunity
(2009) - et al.
Anti-HBs positive occult Hepatitis B virus carrier blood infectious in two transfusion recipients
J. Hepatol.
(2008) - et al.
Attacking Hepatitis B virus cccDNA–the holy grail to Hepatitis B cure
J. Hepatol.
(2016)
Natural history of chronic Hepatitis B
Clin. Liver Dis.
In silico single cell dynamics of Hepatitis B virus infection and clearance
J. Theor. Biol.
Occult Hepatitis B infection
J. Hepatol.
Hepatitis B virus replication is regulated by the acetylation status of Hepatitis B virus cccDNA-bound H3 and H4 histones
Gastroenterology
Real-time PCR quantification of serum and intracellular HBV DNA and HDV RNA in different subsets of chronic HBV infected individuals
Digest. Liver Dis.
Occult Hepatitis B virus infection
J Hepatol
Statements from the Taormina expert meeting on occult Hepatitis B virus infection
J. Hepatol.
Molecular biology of Hepatitis B virus infection
Virology
HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability
Mol. Cell.
The characteristics of the cell-mediated immune response identify different profiles of occult Hepatitis B virus infection
Gastroenterology
The IL-10 promoter polymorphism at position -592 is correlated with susceptibility to occult HBV infection
Inflammation
Characterization of occult Hepatitis B virus strains in South African blood donors
Hepatology
The role of cccDNA in HBV maintenance
Viruses
Proliferation of primary human hepatocytes and prevention of Hepatitis B virus reinfection efficiently deplete nuclear cccDNA in vivo
Gut
Serum levels of IL-10 and IL-17A in occult HBV-infected South-East Iranian patients
Hepatitis Month.
The size of the viral inoculum contributes to the outcome of Hepatitis B virus infection
J. Virol.
Nuclear HBx binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA function
Proc. Natl. Acad. Sci. U S A
Liver cell transformation in chronic HBV infection
Viruses
Modelling post-entry effects of NAPs against HBV infection in vitro
Cellular Genomic Sites of Hepatitis B Virus DNA Integration
Genes
Initial sites of hepadnavirus integration into host genome in human hepatocytes and in the woodchuck model of Hepatitis B-associated hepatocellular carcinoma
Oncogenesis
New insights into Hepatitis B virus biology and implications for novel antiviral strategies
Nation. Sci. Rev.
Virion half-life in chronic Hepatitis B infection is strongly correlated with levels of viremia
Hepatology
Multiploid inheritance of HIV-1 during cell-to-cell infection
J. Virol.
Extracellular vesicles: novel mediator for cell to cell communications in liver pathogenesis
Mole. Aspects Med.
Molecular characterization and functional analysis of occult Hepatitis B virus infection in Chinese patients infected with genotype C
J. Med. Virol.
Hepatitis B virus infection–natural history and clinical consequences
N Engl. J. Med.
Formation of Hepatitis B virus covalently closed circular DNA: removal of genome-linked protein
J. Virol.
Hepatitis delta virus persists during liver regeneration and is amplified through cell division both in vitro and in vivo
Gut
HBV/HCV coinfection and possible reactivation of HBV following DAA use
Gastroenterol. Hepatol.
Modelling the impact of cell-to-cell transmission in Hepatitis B virus
PLoS One
The role of infected cell proliferation in the clearance of acute HBV infection in humans
Viruses
Modeling viral spread
Annu. Rev. Virol.
Immunobiology and pathogenesis of viral Hepatitis
Annu. Rev. Pathol.
Repeated Exposure to trace amounts of woodchuck hepadnavirus induces molecularly evident infection and virus-specific T cell response in the absence of serological infection markers and Hepatitis
J. Virol.
Prevalence of occult Hepatitis B virus infection
World J. Gastroenterol.
Multiscale modeling of Influenza A virus infection supports the development of direct-acting antivirals
PLOS Comput. Biol.
Occult Hepatitis B virus infection: a covert operation
J. Viral. Hepat.
Cited by (14)
Fractional order PD control of the Hopf bifurcation of HBV viral systems with multiple time delays
2023, Alexandria Engineering JournalFractional HBV infection model with both cell-to-cell and virus-to-cell transmissions and adaptive immunity
2022, Chaos, Solitons and FractalsModeling reveals no direct role of the extent of HBV DNA integrations on the outcome of infection
2021, Journal of Theoretical BiologyCitation Excerpt :In the past, mathematical models have played an important role in the study of infectious diseases including HBV (Murray et al., 2005, 2016; Perelson and Nelson, 1999; Perelson, 2002; Mohri, 1998; Perelson et al., 1996; Ciupe et al., 2014; Ribeiro et al., 2010; Dahari et al., 2009; Goyal et al., 2019). Some models have included uncertainty around the fate of cccDNA during cellular proliferation (Murray and Goyal, 2015; Goyal et al., 2017; Murray et al., 2005) while some have included integrations (Goyal and Chauhan, 2018). However, none of these studies have studied the above-mentioned biological processes altogether.
Covalently closed circular DNA: The ultimate therapeutic target for curing HBV infections
2021, Journal of HepatologyCitation Excerpt :For instance, impaired innate immunity,48 genome recycling during replication, secondary infections of neighbouring hepatocytes53 and clearance of infected hepatocytes32 may all impact on the effectiveness of clearing cccDNA during therapy. There have been attempts to more thoroughly understand cccDNA half-life while simultaneously modelling the rates of these other “compartments”, namely cytotoxic T-lymphocytes (CTL) and non-CTL immune responses,63 integration of HBV DNA,64 and cell-to-cell transmission of viral particles.65 These models usually involve sets of ordinary differential equations,66 but have rarely extended to modelling cccDNA levels during therapy.
Dynamic analysis of a fractional-order delayed model for hepatitis B virus with CTL immune response
2020, Virus ResearchCitation Excerpt :The dynamic of virus infection model with CTL response is one of the research hot spot in recent years, which attracted extensive attention in related fields. Many scholars demonstrated the interaction between infected cells and CTLs in vivo through using ordinary differential equations (Lang and Li, 2012; Khabouze et al., 2014; Manna, 2017a, Manna , 2017bXiao et al., 2013; Yang and Xiao, 2012) or delay differential equations (Li and Shu, 2012; Goyal and Chauhan, 2018; Manna, 2017a, Manna, 2017bDanane et al., 2018; Wang et al., 2012). In Danane et al. (2018), two control measures were taken in a delayed HBV model with HBV DNA-containing capsids and CTL immune response.
Within-host mathematical models of hepatitis B virus infection: Past, present, and future
2019, Current Opinion in Systems BiologyCitation Excerpt :Additional insights into within-host HBV infection can be generated using multiscale mathematical models that incorporate intracellular processes. A few theoretical studies have explicitly modeled cccDNA [36,37,39] or IDNA [39], but only one of these studies has incorporated experimental data [37]. Multiscale models can be used to understand the mode(s) of action of new antivirals and their effectiveness in inhibiting various steps in the viral life cycle [63].